Trial · NCT01157117
Participant flow33
How many started, completed or left each group, period by period.
1 to 20 of 33
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Omalizumab/Milk OIT | 28 | |
| Overall Study | STARTED | Placebo for Omalizumab/Milk OIT | 29 | |
| Overall Study | STARTED | Untreated Control | 20 | |
| Overall Study | Began Omalizumab or Placebo Dosing | Omalizumab/Milk OIT | 27 | |
| Overall Study | Began Omalizumab or Placebo Dosing | Placebo for Omalizumab/Milk OIT | 28 | |
| Overall Study | Began Omalizumab or Placebo Dosing | Untreated Control | 0 | |
| Overall Study | Began Milk OIT Dosing at Month 4 | Omalizumab/Milk OIT | 27 | |
| Overall Study | Began Milk OIT Dosing at Month 4 | Placebo for Omalizumab/Milk OIT | 28 | |
| Overall Study | Began Milk OIT Dosing at Month 4 | Untreated Control | 0 | |
| Overall Study | Reached Milk OIT Maintenance Dosing | Omalizumab/Milk OIT | 26 | |
| Overall Study | Reached Milk OIT Maintenance Dosing | Placebo for Omalizumab/Milk OIT | 26 | |
| Overall Study | Reached Milk OIT Maintenance Dosing | Untreated Control | 0 | |
| Overall Study | Unblinded at Month 16 | Omalizumab/Milk OIT | 26 | |
| Overall Study | Unblinded at Month 16 | Placebo for Omalizumab/Milk OIT | 26 | |
| Overall Study | Unblinded at Month 16 | Untreated Control | 0 | |
| Overall Study | Completed Month 28 Desensitization OFC | Omalizumab/Milk OIT | 26 | |
| Overall Study | Completed Month 28 Desensitization OFC | Placebo for Omalizumab/Milk OIT | 24 | |
| Overall Study | Completed Month 28 Desensitization OFC | Untreated Control | 0 | |
| Overall Study | Discontinued Milk OIT at Month 30 | Omalizumab/Milk OIT | 24 | |
| Overall Study | Discontinued Milk OIT at Month 30 | Placebo for Omalizumab/Milk OIT | 20 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01157117/flow